Bionano Genomics, Inc. Debt Instrument, Repurchase Amount
Bionano Genomics, Inc. (BNGO) had Debt Instrument, Repurchase Amount of $49.50 million as of 2025-12-31, per its 10-K filed 2026-03-23.
Financial Statements › Notes › Debt
us-gaap:DebtInstrumentRepurchaseAmount · last filed 2026-03-23
- 2025-12-31: Debt Instrument, Repurchase Amount $49.50M.
- 2025-09-30: Debt Instrument, Repurchase Amount $49.50M.
- 2025-06-30: Debt Instrument, Repurchase Amount $49.50M.
- 2025-03-31: Debt Instrument, Repurchase Amount $49.50M.
| Period end | Debt Instrument, Repurchase Amount |
|---|---|
| 2025-12-31 | $49.50M 10-K · filed 2026-03-23 |
| 2025-09-30 | $49.50M 10-Q · filed 2025-11-13 |
| 2025-06-30 | $49.50M 10-Q · filed 2025-08-14 |
| 2025-03-31 | $49.50M 10-Q · filed 2025-05-14 |
| 2024-12-31 | $49.50M 10-K · filed 2025-03-31 |
| 2024-09-30 | $49.50M 10-Q · filed 2024-11-14 |
| 2024-06-30 | $49.50M 10-Q · filed 2024-08-07 |
| 2024-05-01 | $20.70M 10-K · filed 2026-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |